FDA Inspection
Fresenius Kabi Austria GMBHFresenius Kabi Austria GMBH – FDA Inspection, Feb 8, 2018
Record Details
This FDA Inspection record concerns Fresenius Kabi Austria GMBH, with an inspection on February 8, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- MRA DavisM (Issuing Officer)
View Company Profile
ID · a39580d0-621b-48c0-9739-5f8546032bc4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1094504
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Fresenius Kabi Austria GMBH
12| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 28, 2023 | Not classified | Office of Inspections and Investigations | |
| October 13, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 19, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Fresenius Kabi Austria GMBH
- FDA Inspection 1251340 - 2024-03-21
- FDA Inspection 1205334 - 2023-03-28
- FDA Inspection 1207391 - 2022-10-13
- FDA Inspection 1162216 - 2020-01-30
- FDA Inspection 1052462 - 2018-04-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.